Nuclear Medicine: Page 117

ImaginAb touts prostate cancer study results

By AuntMinnie.com staff writers

Imaging agent developer ImaginAb is touting results from a clinical trial of IAB2M, the company's PET imaging agent for the detection of metastatic prostate cancer.

January 5, 2016

Gamma Medica, Alpha Imaging to partner

By AuntMinnie.com staff writers

Imaging equipment distributor Alpha Imaging has signed an agreement to distribute molecular imaging developer Gamma Medica's LumaGem molecular breast imaging device.

January 5, 2016

Are MPI radiation doses too high in the U.S.? And, technologies to watch in 2016

By Brian Casey

January 4, 2016

Study finds U.S. nuclear cardiology doses are too high

By Eric Barnes

Radiation doses for myocardial perfusion imaging exams in the U.S. are significantly higher than those in the rest of the world. Few U.S. sites adhere to best practices for dose reduction, and the U.S. fee-for-service model also contributes to the disparity, according to articles published online December 28 in JAMA Internal Medicine.

January 4, 2016

Weight-based protocols reduce PET/CT radiation dose

By Wayne Forrest

Patient-specific, weight-based imaging protocols for FDG-PET/CT can significantly reduce CT radiation dose without compromising diagnostic image quality, according to a study from American University of Beirut in Lebanon.

December 27, 2015

MBI: The unsung hero of dense breast imaging?

By Kate Madden Yee

Is molecular breast imaging (MBI) the unsung hero for women with dense breast tissue? Researchers from the Mayo Clinic in Rochester, MN, believe it might be due to its ability to image tumor function. They presented their work with the modality at RSNA 2015.

December 17, 2015

Global cyclotron market to reach $245M in 2030

By AuntMinnie.com staff writers

The global cyclotron market is expected to reach $245 million in 2030, with an annual growth rate of 3%, according to a new market research report by MEDraysintell.

December 16, 2015

It's final: CMS rejects NaF-PET coverage

By AuntMinnie.com staff writers

The U.S. Centers for Medicare and Medicaid Services (CMS) has reaffirmed its decision not to reimburse for sodium fluoride (NaF) PET scans to detect bone metastases.

December 14, 2015

IBA sells last of IBA Molecular

By AuntMinnie.com staff writers

Proton therapy technology developer Ion Beam Applications (IBA) has signed a definitive agreement for the sale of IBA Molecular, which is the remainder of that business after the North American subsidiary was sold earlier this year.

December 13, 2015

PET/MRI shows value for cardiac sarcoidosis

By Wayne Forrest

Simultaneous cardiac PET/MRI is better than PET/CT for detecting cardiac sarcoidosis, offering diagnostic image quality and less radiation dose, according to a study presented at RSNA 2015.

December 13, 2015

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

December 9, 2015

FDA clears VidiStar's nuclear software

By AuntMinnie.com staff writers

PACS developer VidiStar has announced U.S. Food and Drug Administration (FDA) 501(k) clearance of its HeartView nuclear software.

December 6, 2015

Previous Page

Page 117 of 438

Next Page